|
My Onc, nor any of the Oncs where I am treated do annual scans. This is a question that I've been musing about for a while-- does the management of the disease change at all with the use of Herceptin in the adjuvent/early-stage setting (as opposed to advanced breast cancer). If there was a recurrance that was caught earlier due to annual screens, would it be more easily treated with a better prognosis than waiting for symptoms? Not sure anyone has the answer to that. Also wondering if any Oncs would treat rising CA or HER2 serum #s with Herceptin while a patient was still NED.
Jen
|